Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA; Faculty of Medicine, Université Saint Joseph de Beyrouth, Beirut, Lebanon.
Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Mult Scler Relat Disord. 2021 Jul;52:103015. doi: 10.1016/j.msard.2021.103015. Epub 2021 May 7.
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is a rare fatal autosomal dominant vasculopathy associated with mutations in the TREX1 gene. Only one de novo case has been reported in the literature. We report the long-term clinical, radiological, and pathological presentation of a patient with a de novo and novel mutation in this gene. Description of the clinical, genetic, imaging and pathologic characteristics is important to better characterize RVCL-S and prevent unnecessary interventions. RVCL-S should be considered in patients with tumefactive brain lesions unresponsive to immunotherapy.
视网膜血管病伴脑白质病和全身表现(RVCL-S)是一种罕见的致命常染色体显性血管病,与 TREX1 基因突变有关。文献中仅报道过一例新发病例。我们报告了一例该基因新发和新突变患者的长期临床、放射学和病理学表现。描述临床、遗传、影像学和病理学特征对于更好地表征 RVCL-S 并防止不必要的干预非常重要。对于对免疫治疗无反应的肿块性脑病变患者,应考虑 RVCL-S。